Physician profile
Param B Singh
NPI 1891859708
$30,020.52
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $4,100 · 2021: $10K · 2022: $1,800.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $6,700.00 | 2021 | |
| Emd Serono, INC. | $6,560.00 | 2019 | |
| Ptc Therapeutics, INC. | $3,595.95 | 2019 | |
| Bioventus LLC | $3,487.07 | 2019 | |
| Biogen, INC. | $2,800.00 | 2020 | |
| Seagen INC. | $2,775.00 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $1,800.00 | 2022 | |
| Genentech USA, INC. | $1,760.00 | 2021 | |
| Daiichi Sankyo INC. | $542.50 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Param Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.